JP2024515347A5 - - Google Patents
Info
- Publication number
- JP2024515347A5 JP2024515347A5 JP2023564511A JP2023564511A JP2024515347A5 JP 2024515347 A5 JP2024515347 A5 JP 2024515347A5 JP 2023564511 A JP2023564511 A JP 2023564511A JP 2023564511 A JP2023564511 A JP 2023564511A JP 2024515347 A5 JP2024515347 A5 JP 2024515347A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- variant
- nucleotide sequence
- sequence identity
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2105686.6 | 2021-04-21 | ||
| GBGB2105686.6A GB202105686D0 (en) | 2021-04-21 | 2021-04-21 | Chimeric antigen receptor (CAR)-T cells |
| PCT/GB2022/051004 WO2022223976A1 (en) | 2021-04-21 | 2022-04-21 | Chimeric antigen receptor (car)-t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515347A JP2024515347A (ja) | 2024-04-09 |
| JP2024515347A5 true JP2024515347A5 (enExample) | 2025-04-25 |
Family
ID=76377622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564511A Pending JP2024515347A (ja) | 2021-04-21 | 2022-04-21 | キメラ抗原受容体（ｃａｒ）－ｔ細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240207313A1 (enExample) |
| EP (1) | EP4326760A1 (enExample) |
| JP (1) | JP2024515347A (enExample) |
| KR (1) | KR20240032719A (enExample) |
| CN (1) | CN117769566A (enExample) |
| AU (1) | AU2022262697A1 (enExample) |
| CA (1) | CA3215842A1 (enExample) |
| GB (1) | GB202105686D0 (enExample) |
| WO (1) | WO2022223976A1 (enExample) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245262B2 (en) | 2014-04-01 | 2019-04-02 | The University Of Queensland | Immunological reagents and uses therefor |
| GB201506423D0 (en) * | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| ES2851123T1 (es) * | 2014-09-26 | 2021-09-03 | Baylor College Medicine | Receptores quiméricos de antígeno específicos de glipicano-3 para inmunoterapia adoptiva |
| CA2977106A1 (en) * | 2015-02-27 | 2016-09-01 | Icell Gene Therapeutics Llc | Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof |
| CN109897114B (zh) * | 2017-12-08 | 2022-08-02 | 亘喜生物科技（上海）有限公司 | 具有自杀基因开关的靶向cd47的工程化免疫细胞 |
| GB201800298D0 (en) * | 2018-01-09 | 2018-02-21 | Autolus Ltd | Method |
| CN113286875B (zh) * | 2018-12-19 | 2024-08-09 | Inserm(法国国家健康医学研究院) | 表达嵌合抗原受体的黏膜相关不变t(mait)细胞 |
| WO2020156335A1 (zh) * | 2019-01-29 | 2020-08-06 | 上海交通大学 | 一种嵌合抗原受体及其应用 |
| WO2021155112A1 (en) * | 2020-01-29 | 2021-08-05 | The Trustees Of The University Of Pennsylvania | Compositions and methods of t cell receptor vb family member targeting for the treatment of t cell associated disease |
-
2021
- 2021-04-21 GB GBGB2105686.6A patent/GB202105686D0/en not_active Ceased
-
2022
- 2022-04-21 US US18/287,556 patent/US20240207313A1/en active Pending
- 2022-04-21 CN CN202280044138.4A patent/CN117769566A/zh active Pending
- 2022-04-21 AU AU2022262697A patent/AU2022262697A1/en active Pending
- 2022-04-21 KR KR1020237039736A patent/KR20240032719A/ko active Pending
- 2022-04-21 WO PCT/GB2022/051004 patent/WO2022223976A1/en not_active Ceased
- 2022-04-21 CA CA3215842A patent/CA3215842A1/en active Pending
- 2022-04-21 JP JP2023564511A patent/JP2024515347A/ja active Pending
- 2022-04-21 EP EP22720012.8A patent/EP4326760A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112300269B (zh) | Kras突变特异性t细胞受体筛选及抗肿瘤用途 | |
| JP7223822B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ６ ｔ細胞受容体 | |
| JP7744479B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体 | |
| JP2024514355A5 (enExample) | ||
| JP7574243B2 (ja) | 抗ｃｄ７０キメラ抗原受容体 | |
| JP7270001B2 (ja) | Ｍｈｃクラスｉｉ拘束性ｍａｇｅ－ａ３を認識するｔ細胞受容体 | |
| JP7684047B2 (ja) | インターロイキン１５融合タンパク質、およびその組成物ならびに治療方法 | |
| JP7385566B2 (ja) | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 | |
| AU2017258745B2 (en) | Anti-KK-LC-1 T cell receptors | |
| JP2022109953A5 (enExample) | ||
| KR102557834B1 (ko) | 신규의 세포 태그의 발현 | |
| JP2020096630A5 (enExample) | ||
| CN103483452B (zh) | 双信号独立的嵌合抗原受体及其用途 | |
| JPH07501698A (ja) | 二価特異性ヘテロ二量体 | |
| CN108137703A (zh) | 抗cd30嵌合抗原受体 | |
| JP2023528112A (ja) | Ｇ１２ｄ突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 | |
| CN110157738A (zh) | 靶向cd19和cd22的工程化免疫细胞及其应用 | |
| JP7672979B2 (ja) | Ｇ１２ｒ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| JP2023527613A (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| CN111850014A (zh) | 一种细胞因子增效的嵌合抗原受体及其应用 | |
| CN116284430A (zh) | 靶向肿瘤的il15融合蛋白及其应用 | |
| KR102764613B1 (ko) | NaPi2b 특이적 CAR-T를 포함하는 난소암 치료용 약학 조성물 | |
| WO2020257575A1 (en) | T-cell receptor for treating fibrolamellar hepatocellular carcinoma | |
| US20260070957A1 (en) | Interleukin 15 fusion proteins, and compositions and therapeutic methods thereof | |
| WO2025029881A1 (en) | Combination therapy with a sirpa-based chimeric protein and azacitidine |